TRIB
Trinity Biotech
TRIB
TRIB
26 hedge funds and large institutions have $10.8M invested in Trinity Biotech in 2019 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
Holders
26
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$226K | |
| 2 | +$144K | |
| 3 | +$97.3K | |
| 4 |
Renaissance Technologies
New York
|
+$7.02K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$4K |
Top Sellers
| 1 | -$884K | |
| 2 | -$251K | |
| 3 | -$142K | |
| 4 |
ARM
Adirondack Research & Management
Guilderland,
New York
|
-$64.7K |
| 5 |
Verition Fund Management
Greenwich,
Connecticut
|
-$15K |